Sequential re-rating: management describes the same offering landing bigger the second and third time around
The model's full reasoning — Q4 2016 call → NOWe need to determine if management describes that successive engagements of the same kind are coming in at progressively larger size. The question asks about a specific phenomenon: the unit size of the company's repeatable business is escalating. We need to look for management's own words conveying that the deals, orders, contracts, projects, customers, sites, or programs they are landing now are individually bigger, broader, or longer than before for the same offering. Let's scan the transcript for any such statements. The call covers Q4 2016 results. Management discusses various segments: asset-based LTL, asset-light (expedited, truckload, international, FleetNet). They talk about revenue growth, tonnage, shipments, pricing, etc. But do they mention that the size of individual contracts, orders, or engagements is increasing? For example, do they say that new customers are larger, or that contracts are bigger, or that they are winning larger deals? I see mentions of acquisitions, but that's not about the size of engagements. They talk about "enhanced market approach" and "integrated solutions" but not about deal size escalation. They mention that they are seeing more e-commerce shipments, but that's about mix, not about larger individual engagements. They talk about pricing improvements, but that's price per unit, not size of engagement. The question specifically asks about "successive engagements of the same kind" coming in at "progressively larger size." There is no mention of that. Management does not say that the average size of new orders has stepped up, or that customers are starting at a larger scale, or that follow-on commitments are larger. They talk about shipment counts increasing, but that's volume, not size per engagement. They talk about weight per shipment decreasing, which is actually the opposite—smaller shipments. So the unit size of shipments is shrinking, not growing. Thus, the answer is NO. The management does not convey that the size of individual engagements is escalating. In fact, they note that weight per shipment is declining, which is a decrease in size per shipment. So clearly not. Therefore, answer NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASO | Academy Sports and Outdoors, Inc. | Q1 2024 | 2024-06-11 | C+ |
| AKYA | Akoya Biosciences, Inc. | Q2 2023 | 2023-08-07 | C+ |
| SPT | Sprout Social, Inc. | Q2 2023 | 2023-08-04 | B+ |
| SGRY | Surgery Partners, Inc. | Q2 2022 | 2022-08-02 | B+ |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| ASAN | Asana, Inc. | Q2 2022 | 2021-09-01 | B+ |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
AKYA · Q2 2023 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing a clear pattern of escalating project sizes in the translational/clinical space. Brian notes a migration from exploratory studies (reasonable size) to larger retrospective studies and even larger retrospective-prospective ongoing clinical studies, with projects moving "further and further downstream.
ASAN · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES Management describes exactly this pattern. Dustin notes the company is “closing larger deals and expanding seats across departments and geographies quickly in large organizations,” and that the growth in the >$50k cohort “reflected an acceleration in our largest enterprise customers.
SGRY · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing exactly this pattern for physician recruiting cohorts. Wayne notes that the 2022 cohorts are “no exception to this trend, bringing more cases with a higher overall net revenue per case than our 2021 cohorts did in the same period last year.